Pancreatic Cancer Vaccine Shows Promise in Human Trial

A pancreatic cancer vaccine developed by Johns Hopkins has shown promise in its first human trial, triggering immune responses in 90% of high-risk participants and causing some cysts to shrink.

22 Jul, 13:36 — 22 Jul, 13:36

Post Share

Sources

Showing 1 of 2 sources

Fox NewsMixed42d ago

Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients

A Johns Hopkins pancreatic cancer vaccine triggered immune responses in 90% of high-risk participants, with some cysts shrinking after vaccination.

Read full article →

Coverage Timeline

First report: Fox News · 22 Jul, 13:36|Full coverage: 2 · 43m|Window: 43m

Left-leaningCenterRight-leaning

Fox News22 Jul, 13:36First to report

Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients

tvn2422 Jul, 14:19Latest update

Pancreatic Cancer Vaccine Shows Promise in Human Trial

Sources

Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients

Coverage Timeline

Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients

Pierwszy test szczepionki na raka trzustki. Odpowiedź u 90 procent badanych

Related Stories

Mbappé-Backed Health Startup Alan Expands Into West Africa

Boehringer Signs AI Drug Discovery Deal With Owkin

Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites

New Urine Test Detects Over 90 Percent of Bladder Cancer Cases